Found: 16
Select item for more details and to access through your institution.
Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 3, p. 444, doi. 10.1111/bjh.13977
- By:
- Publication type:
- Article
Results of a phase I trial with Haploidentical mbIL‐21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 890, doi. 10.1002/ajh.27281
- By:
- Publication type:
- Article
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 9, p. 1383, doi. 10.1002/ajh.26997
- By:
- Publication type:
- Article
Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 4, p. 485, doi. 10.1016/j.clml.2013.02.023
- By:
- Publication type:
- Article
CT-046: Post-Transplant Cyclophosphamide in HLA-Matched and Haploidentical Transplant Recipients Receiving a Myeloablative Fractionated Busulfan Conditioning Regimen: Results of a Phase II Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S446, doi. 10.1016/S2152-2650(21)01992-3
- By:
- Publication type:
- Article
Poster: CT-046: Post-Transplant Cyclophosphamide in HLA-Matched and Haploidentical Transplant Recipients Receiving a Myeloablative Fractionated Busulfan Conditioning Regimen: Results of a Phase II Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S258, doi. 10.1016/S2152-2650(21)01627-X
- By:
- Publication type:
- Article
Haploidentical transplants for patients with relapse after the first allograft.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1187, doi. 10.1002/ajh.25924
- By:
- Publication type:
- Article
Haploidentical transplants for patients with graft failure after the first allograft.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. E267, doi. 10.1002/ajh.25917
- By:
- Publication type:
- Article
Curative potential of hematopoietic stem cell transplantation for advanced psoriasis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 6, p. E176, doi. 10.1002/ajh.25470
- By:
- Publication type:
- Article
Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. 331, doi. 10.1002/ajh.24632
- By:
- Publication type:
- Article
Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective case-control study.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 198, doi. 10.1002/ajh.23371
- By:
- Publication type:
- Article
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
- Published in:
- Acta Haematologica, 2021, v. 144, n. 1, p. 74, doi. 10.1159/000507012
- By:
- Publication type:
- Article
Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation.
- Published in:
- Acta Haematologica, 2019, v. 142, n. 3, p. 176, doi. 10.1159/000495456
- By:
- Publication type:
- Article
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes.
- Published in:
- 2020
- By:
- Publication type:
- journal article